Pinnacle Associates’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.4M Sell
21,248
-389
-2% -$211K 0.13% 162
2025
Q4
$12.5M Sell
21,637
-2,449
-10% -$1.38M 0.16% 133
2025
Q3
$11.7M Buy
24,086
+534
+2% +$249K 0.16% 144
2025
Q2
$9.55M Sell
23,552
-709
-3% -$296K 0.14% 169
2025
Q1
$12.1M Sell
24,261
-8,457
-26% -$4.58M 0.18% 125
2024
Q4
$17M Sell
32,718
-1,994
-6% -$1.1M 0.23% 97
2024
Q3
$18.4M Buy
34,712
+511
+1% +$302K 0.31% 92
2024
Q2
$18.9M Sell
34,201
-116
-0.3% -$66.5K 0.3% 89
2024
Q1
$19.9M Sell
34,317
-395
-1% -$222K 0.31% 84
2023
Q4
$18.4M Sell
34,712
-467
-1% -$226K 0.31% 93
2023
Q3
$17.8M Buy
35,179
+770
+2% +$410K 0.33% 85
2023
Q2
$18M Buy
34,409
+8,145
+31% +$4.4M 0.31% 91
2023
Q1
$15.1M Sell
26,264
-473
-2% -$267K 0.31% 94
2022
Q4
$14.7M Sell
26,737
-164
-0.6% -$86.9K 0.32% 89
2022
Q3
$13.6M Buy
26,901
+762
+3% +$426K 0.31% 95
2022
Q2
$14.2M Buy
26,139
+481
+2% +$265K 0.31% 97
2022
Q1
$15.2M Buy
25,658
+401
+2% +$230K 0.27% 110
2021
Q4
$16.9M Sell
25,257
-138
-0.5% -$86.2K 0.29% 107
2021
Q3
$14.5M Sell
25,395
-585
-2% -$321K 0.27% 107
2021
Q2
$13.1M Sell
25,980
-2,667
-9% -$1.26M 0.24% 118
2021
Q1
$13.1M Sell
28,647
-511
-2% -$244K 0.25% 115
2020
Q4
$13.6M Sell
29,158
-169
-0.6% -$79.2K 0.28% 102
2020
Q3
$12.9M Buy
29,327
+300
+1% +$124K 0.31% 92
2020
Q2
$10.5M Sell
29,027
-5,170
-15% -$1.73M 0.26% 105
2020
Q1
$9.7M Sell
34,197
-1,608
-4% -$507K 0.29% 97
2019
Q4
$11.6M Sell
35,805
-749
-2% -$227K 0.25% 107
2019
Q3
$10.6M Sell
36,554
-2,622
-7% -$751K 0.25% 113
2019
Q2
$11.5M Buy
39,176
+12,728
+48% +$3.51M 0.27% 104
2019
Q1
$7.24M Sell
26,448
-1,046
-4% -$260K 0.16% 163
2018
Q4
$6.15M Buy
27,494
+1,551
+6% +$364K 0.16% 165
2018
Q3
$6.33M Sell
25,943
-3,050
-11% -$702K 0.13% 182
2018
Q2
$6.01M Sell
28,993
-164
-0.6% -$34.8K 0.12% 193
2018
Q1
$6.02M Buy
29,157
+278
+1% +$58.4K 0.12% 189
2017
Q4
$5.48M Sell
28,879
-1,075
-4% -$206K 0.11% 198
2017
Q3
$5.67M Sell
29,954
-2,425
-7% -$439K 0.1% 192
2017
Q2
$5.65M Sell
32,379
-225
-0.7% -$37.8K 0.11% 187
2017
Q1
$5.01M Sell
32,604
-2,585
-7% -$395K 0.1% 200
2016
Q4
$4.96M Buy
35,189
+606
+2% +$89.3K 0.1% 196
2016
Q3
$5.5M Sell
34,583
-200
-0.6% -$30.8K 0.11% 186
2016
Q2
$5.14M Sell
34,783
-75
-0.2% -$11.1K 0.11% 194
2016
Q1
$4.94M Sell
34,858
-4,015
-10% -$538K 0.11% 195
2015
Q4
$5.51M Buy
38,873
+150
+0.4% +$20K 0.12% 178
2015
Q3
$4.74M Hold
38,723
0.1% 191
2015
Q2
$5.03M Sell
38,723
-375
-1% -$48.9K 0.09% 198
2015
Q1
$5.25M Sell
39,098
-611
-2% -$78.8K 0.1% 190
2014
Q4
$4.97M Buy
39,709
+475
+1% +$57.8K 0.1% 194
2014
Q3
$4.78M Sell
39,234
-1,200
-3% -$146K 0.1% 191
2014
Q2
$4.77M Sell
40,434
-1,250
-3% -$147K 0.09% 188
2014
Q1
$5.01M Sell
41,684
-550
-1% -$65.4K 0.1% 178
2013
Q4
$4.7M Sell
42,234
-350
-0.8% -$34.8K 0.09% 193
2013
Q3
$3.92M Sell
42,584
-187
-0.4% -$16.9K 0.08% 196
2013
Q2
$3.62M Buy
+42,771
New +$3.56M 0.08% 198

Other funds holding TMO

Pinnacle Associates's TMO Position: Q1 2026 in Review

Pinnacle Associates reduced its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, selling an estimated $211K and leaving 21,248 shares worth $10.4M. The position accounts for 0.13% of the portfolio, ranked #162.

Pinnacle Associates first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.9M in Q1 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Pinnacle Associates held 21,248 shares of Thermo Fisher Scientific worth $10.4M as of Q1 2026.
  • Pinnacle Associates sold 389 Thermo Fisher Scientific shares in Q1 2026, an estimated $211K.
  • Thermo Fisher Scientific made up 0.13% of Pinnacle Associates's portfolio in Q1 2026, its #162 holding.
  • Pinnacle Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's Thermo Fisher Scientific position peaked at $19.9M in Q1 2024.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.